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Drosophila p53 Is a Structural
and Functional Homolog of the Tumor
Suppressor p53
apoptosis (Wagner et al., 1994). In fact, p21 may protect
against p53-induced apoptosis in at least some cell
types (Waldman et al., 1996; Wang and Walsh, 1996;
Gorospe et al., 1997; Bissonnette and Hunting, 1998;
Yu et al., 1998; Asada et al., 1999).
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For example, p53 can transcriptionally activate the pro-South San Francisco, California 94080
apoptotic genes Bax (Miyashita and Reed, 1995), Fas²Department of Biological Sciences
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apoptosis through the formation of reactive oxygen spe-
cies (Polyak et al., 1997). Furthermore, there is evidence
that p53 can induce apoptosis in the absence of itsSummary
transcriptional activation function (reviewed in Ko and
Prives, 1996).The importance of p53 in carcinogenesis stems from
The recent discovery of two p53-related genes, p63its central role in inducing cell cycle arrest or apoptosis
and p73, has revealed an additional level of complexityin response to cellular stresses. We have identified a
to studying p53 function in vertebrates (Kaelin, 1999).Drosophila homolog of p53 (ªDmp53º). Like mamma-
Both genes encode proteins with transactivation, DNA-lian p53, Dmp53 binds specifically to human p53 bind-
binding, and tetramerization domains, and some iso-ing sites, and overexpression of Dmp53 induces apopto-
forms of p63 and p73 are capable of transactivatingsis. Importantly, inhibition of Dmp53 function renders
p53 target genes and inducing apoptosis. It was initiallycells resistant to X ray±induced apoptosis, suggesting
thought that only p53 was induced in response to DNAthat Dmp53 is required for the apoptotic response to
damage and other stress signals. There is now evidence,DNA damage. Unlike mammalian p53, Dmp53 appears
however, that p73 is also activated by some forms ofunable to induce a G1 cell cycle block when overex-
DNA damage in a manner that is dependent upon thepressed, and inhibition of Dmp53 activity does not
c-Abl tyrosine kinase (Agami et al., 1999; Gong et al.,affect X ray±induced cell cycle arrest. These data re-
1999; Yuan et al., 1999). These data suggest that p53-veal an ancestral proapoptotic function for p53 and
independent apoptotic pathways may be mediated byidentify Drosophila as an ideal model system for eluci-
other p53 family members.dating the p53 apoptotic pathway(s) induced by DNA
A better understanding of p53-regulated pathwaysdamage.
could lead to improved strategies for treating p53-defi-
cient tumors. However, the apparent complexity of p53
Introduction function in vertebrates has hampered efforts to eluci-
date these pathways. The fruit fly Drosophila has proven
p53 is a tightly regulated transcription factor that in- to be a powerful tool for the genetic dissection of bio-
duces cell cycle arrest or apoptosis in response to cellu- chemical pathways. We report the identification of a
lar stresses such as DNA damage and oncogene activa- Drosophila homolog of p53 (the abbreviation ªDmp53º
tion (Ko and Prives, 1996; Levine, 1997; Giaccia and will be used here to distinguish Drosophila p53 from
Kastan, 1998; Kamijo et al., 1998). Loss or inactivation other family members). Dmp53 shares significant amino
of the p53 tumor suppressor gene is the single most acid identity with the DNA-binding domain of p53, in-
common mutation in human cancer (Hainaut et al., 1998). cluding conservation of key residues commonly mu-
Thus, inactivation of p53 function may provide a selec- tated in human cancer. Like p53, overexpression of
tive advantage to tumor cells through accrued mutations Dmp53 induces apoptosis, and inhibition of Dmp53
leading to deregulated cell proliferation and resistance function renders cells resistant to X ray±induced apopto-
to cell death (Graeber et al., 1996; Kinzler and Vogelstein, sis. In contrast to mammalian p53, Dmp53 overexpres-
1996). sion does not induce a G1 cell cycle block, and inhibition
Numerous studies have established that growth arrest of Dmp53 activity does not affect X ray±induced cell
and apoptosis are independent functions of p53 (re- cycle arrest. These data suggest that the ancestral func-
tion of p53 may have been restricted to eliminating dam-viewed in Gottlieb and Oren, 1996). p53-dependent G1
aged cells by apoptosis and identify Drosophila as anarrest occurs largely through transcriptional induction
ideal model system for dissecting p53-mediated apo-of p21WAF1, which prevents entry into S phase by inhib-
ptotic pathways.iting G1 cyclin±dependent kinase activity (el-Deiry et al.,
1993; Harper et al., 1993; Xiong et al., 1993; Deng et al.,
Results1995). However, p21 is not required for p53-dependent
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Figure 1. Dmp53 Sequence Conservation
and Predicted Structure
(A) Predicted amino acid sequence of Dmp53.
(B) Alignment of DNA-binding domains of
p53-related proteins from human (Hs), Dro-
sophila melanogaster (Dm), Tribolium casta-
neum (Tc), and Leptinotarsa decemlineata
(Ld). Positions at which 50% or more of the
residues are identical are shaded in black,
and conservative substitutions are shaded in
gray. Positions are left unshaded if one resi-
due is conserved among the three human
proteins and a different residue is conserved
among the three insect proteins (unless it rep-
resents a conservative substitution). Resi-
dues that form the zinc ion coordination site
in p53 are indicated in blue. DNA contact resi-
dues are indicated in green. Red asterisks
mark residues altered in the Dmp53 domi-
nant-negative mutations R155H and H159N.
(C) Two views of a surface representation
model of the Dmp53 DNA-binding domain
(residues 90±275). The model is derived from
the crystal structure of human p53 (Cho et
al., 1994). The left view shows the predicted
DNA-binding face of Dmp53, the right view
shows the protein rotated 1808. Colored resi-
dues are those conserved between Dmp53
and the vertebrate p53 family (38% similarity,
including conservative substitutions). Resi-
dues in green correspond to DNA contact res-
idues in human p53. Residues in blue high-
light the zinc ion coordination site. All other
conserved residues are shown in yellow;
most of these are involved in formation of the
DNA-binding pocket or in structural packing.
large-scale expressed sequence tag (EST) project. There is no sequence similarity between Dmp53 and
other p53 family members in the carboxyl termini, yetNorthern blot analysis using the cDNA probe revealed
a single 1.6 kb transcript in embryos, larvae, and adults this region of Dmp53 contains secondary structures
characteristic of p53-related proteins. Mammalian p53(data not shown). The complete sequence of the Dmp53
mRNA was obtained by rapid amplification of cDNA binds DNA as a homotetramer, and self-association is
mediated by a b sheet and amphipathic a helix locatedends (RACE) and sequencing of a 1.6 kb cDNA clone.
The cDNA encodes a putative 385 amino acid protein in the carboxyl terminus of the protein (Clore et al., 1994;
Lee et al., 1994; Jeffrey et al., 1995). A similar b sheet(Figure 1A). Hybridization of a Dmp53 probe to polytene
chromosomes localized the gene to chromosome 3, (residues 320±322 and 332±337) and amphipathic a helix
(residues 341±359) are predicted in the carboxyl termi-band 94D. We also identified additional insect p53-
related genes through EST sequencing projects in the nus of Dmp53. Consistent with this prediction, a yeast
two-hybrid assay revealed that Dmp53 interacts withflour beetle (Tribolium castaneum) and Colorado potato
beetle (Leptinotarsa decemilineata). itself but not with human p53 (data not shown). Like the
carboxyl terminus, the amino terminus of Dmp53 showsHuman p53 is a 393 amino acid protein composed of
three main functional domains: an amino-terminal acidic no sequence similarity with other p53 family members.
However, this region is highly divergent among p53 fam-transactivation domain, a central DNA-binding domain,
and a carboxy-terminal tetramerization domain. Signifi- ily members, except for conserved residues critical for
binding of MDM2 to human p53 (Lin et al., 1994; Kussiecant similarity between Dmp53 and the vertebrate p53
family is limited to the DNA-binding domain and includes et al., 1996). Interestingly, the residues critical for MDM2
binding are not conserved in Dmp53.residues identified in human p53 as critical for DNA
sequence recognition and coordination of a zinc ion p53-related sequences have been described pre-
viously in invertebrates, including clams (Barker et al.,(Figures 1B and 1C) (Cho et al., 1994). We generated
a three-dimensional model of the Dmp53 DNA-binding 1997; Van Beneden et al., 1997) and squid (Schmale and
Bamberger, 1997). Squid p53 more closely resemblesdomain based on the human p53 crystal structure (Fig-
ure 1C) (Cho et al., 1994). Conserved surface residues p63 or p73 because of its long C-terminal extension that
contains the SAM domain characteristic of the p63/p73predominantly cluster in the DNA-binding site, while
most of the remaining conserved residues are buried subfamily (Figure 2). This led to the suggestion that p53
may have evolved from an ancestral p73-like moleculeand involved in stabilizing the tertiary fold of the domain.
This suggests that, despite limited sequence identity, (Kaghad et al., 1997). Dmp53 lacks a carboxy-terminal
SAM domain, and there is no evidence for a SAM do-the Dmp53 DNA-binding domain may adopt a tertiary
structure similar to the human p53 DNA-binding domain. main±containing alternative exon within the 100 kb of
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mutations in human p53 produce proteins with domi-
nant-negative activity, presumably because they cannot
bind DNA but retain a functional tetramerization domain
(Brachmann et al., 1996; reviewed in Vogelstein and
Kinzler, 1992). Thus, DNA binding by any tetramer that
incorporates the mutant protein is disrupted. Both
Dmp53R155H and H159N proteins inhibit binding of
wild-type Dmp53 to a p53 binding site (Figure 3C, lanes
1±5), although they did not bind to DNA themselves.
As described below, these mutant forms of Dmp53 are
useful tools to test the function of wild-type Dmp53
in vivo.
Dmp53 Overexpression Induces Apoptosis
but Not G1 ArrestFigure 2. Phylogenetic Analysis of the p53 Gene Family
To determine whether Dmp53 can serve the same func-Phylogenetic tree generated with Clustal W shows the relationship
tions in vivo as human p53, we ectopically expressedof p53-related proteins from Loligo forbesi (Lf), Barbus barbus (Bb),
Mus musculus (Mm), Homo sapiens (Hs), Xenopus laevis (Xl), Danio Dmp53 in Drosophila larval eye discs using glass-
rerio (Dr), Leptinotarsa decemlineata (Ld), Tribolium castaneum (Tc), responsive enhancer elements (Hay et al., 1994). The
and Drosophila melanogaster (Dm). glass-Dmp53 (gl-Dmp53) transgene expresses Dmp53
in all cells posterior to the morphogenetic furrow. The
morphogenetic furrow marks the front of a wave of cellu-
genomic sequence downstream of Dmp53. The beetle lar differentiation that sweeps from the posterior to the
p53 proteins also lack any similarity to the carboxy- anterior of the eye disc during larval development (Wolff
terminal domains of p63 and p73. Given that the insect and Ready, 1991). Thus, gl-Dmp53 larvae express
p53-related genes represent the most evolutionarily dis- Dmp53 in all eye disc cells as they differentiate as well
tant members of the p53 gene family known to date, as in a subset of cells behind the furrow that undergo a
we suggest that the p63/p73 subfamily arose from an final round of cell division before terminal differentiation.
ancestral p53-like gene after the split of the arthropod Expression of Dmp53 from the gl-Dmp53 transgene
and vertebrate lineages. produces viable adults that have small, rough eyes with
fused ommatidia (Figure 4B). TUNEL staining of gl-
Dmp53 eye discs shows that this phenotype is due, atDmp53 Binds to Human p53 Recognition Sites
in p21 and GADD45 least in part, to widespread apoptosis in cells expressing
Dmp53 (Figure 4D). Similar results are seen when apo-To determine whether the sequence similarity of Dmp53
and p53 may reflect a conserved function as a DNA ptotic cells are detected by acridine orange or Nile Blue
(data not shown). TUNEL-positive cells appear withinbinding transcription factor, we tested whether Dmp53
can bind to a double-stranded DNA molecule containing 15±30 cell diameters of the furrow. Given that the furrow
is estimated to move approximately five cell diametersa p53 recognition site using an electrophoretic mobility
shift assay. Figure 3 shows that Dmp53 binds specifi- per hour (Wolff and Ready, 1991), this indicates that
cells initiate apoptosis within 3±6 hr after Dmp53 is ex-cally to oligonucleotides containing p53 binding sites
from the human p21 and GADD45 genes, demonstrating pressed.
The ability of p53 to induce apoptosis in some verte-that both DNA binding and target site specificity have
been conserved through more than 500 million years brate cell types can be inhibited by overexpression of
p21. The precise mechanism(s) through which p21 inhib-of evolution. This interaction is specific, as addition of
unlabelled wild-type GADD45 oligoduplex DNA com- its apoptosis is unknown, but direct inhibitory interac-
tions with procaspase 3 (Suzuki et al., 1999a, 1999b)petes for Dmp53 binding, whereas unlabelled mutant
GADD45 oligoduplex DNA does not (Figure 3A, lanes and apoptosis signal-regulating kinase 1 (Asada et al.,
1999) have been reported. To determine if expression5±8). Moreover, an anti-Dmp53 polyclonal antibody pre-
vents DNA binding by Dmp53 (Figure 3A, lane 4), and of human p21 can similarly suppress Dmp53-induced
apoptosis, we coexpressed Dmp53 and p21 in the devel-an anti-Dmp53 monoclonal antibody supershifts the
Dmp53/DNA complex (Figure 3B, lane 4). It is interesting oping eye disc. p21 expression dramatically suppresses
Dmp53-induced apoptosis in the disc (Figures 4I andthat human p53, which was expressed and tested in
an identical assay, bound p53 binding sites only in the 4J) as well as the adult rough-eye phenotype (data not
shown). This suppression does not appear to involvepresence of the activating antibody PAb421 (data not
shown). PAb421 is thought to act by associating with a reduction of p53 protein levels, since matched disc sam-
ples from larvae expressing gl-Dmp53 (Figure 4I) or gl-region in the carboxyl terminus of p53 that normally
negatively regulates DNA binding (Hupp et al., 1992). Dmp53 plus gl-p21 (Figure 4J) show similar levels of
anti-Dmp53 antibody staining. These data suggest thatThe ability of Dmp53 to bind DNA without any activating
treatments may indicate that a similar negative regula- p53-related proteins in flies and vertebrates trigger apo-
ptosis through similar p21-suppressible pathways. Sur-tory element does not exist in Dmp53.
We generated mutant alleles of Dmp53 analogous to prisingly, we were unable to achieve similar inhibition
of apoptosis by coexpression of the baculovirus p35the R175H (R155H in Dmp53) and H179N (H159N in
Dmp53) tumor-derived mutations in human p53. These protein, a universal substrate inhibitor of caspases (data
Cell
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Figure 3. Wild-Type Dmp53 Binds Specifically to Human p53 Binding Sites, and This Binding Is Inhibited by Dmp53R155H and H159N Mutants
H1299 cells were transiently transfected with plasmids expressing either wild-type Dmp53, Dmp53R155H (155), or Dmp53H159N (159). A
mammalian whole-cell extract was prepared (see Experimental Procedures), and 20 mg was used for electrophoretic mobility shift assays
(EMSA) and Western blot analysis.
(A) EMSA showing the ability of wild-type Dmp53 to bind 32P-labeled oligonucleotides containing the p53-binding element from GADD45.
Antibodies were added as indicated: lane 3, preimmune serum, and lane 4, polyclonal anti-Dmp53 serum. Wild-type or mutant GADD45
oligonucleotides were added in 10-fold (lanes 5 and 7) or 30-fold (lanes 6 and 8) molar excess over probe. Lane 1 contains an extract from
cells expressing an empty CMV vector. Lanes 2±8 contain extracts expressing wild-type CMV-Dmp53. Lane 9 contains a reaction mixture
lacking extract.
(B) EMSA showing the ability of wild-type Dmp53/GADD45 complexes to be supershifted by the monoclonal anti-Dmp53 H1 antiserum (lane
4). Lane 1 contains a reaction mixture lacking extract. Lane 2 contains an extract from cells expressing an empty CMV vector. Lanes 3 and
4 contain an extract from cells expressing wild-type CMV-Dmp53.
(C) Dmp53 mutant proteins inhibit binding by wild-type Dmp53 to p21-binding site oligonucleotides. For each cotransfection (lanes 1±6), a
constant amount of DNA (1 mg) was used for each expression vector (ªWT,º ª155,º and ª159º refer to wild-type Dmp53, Dmp53R155H, and
Dmp53H159N, respectively) or control (ªCº refers to empty CMV vector) for a total of 2 mg. Lane 6 reaction mixture lacks extract.
(D) Western blot loaded with 20 mg of extract utilized in (C) and probed with anti-Dmp53 polyclonal antibody to detect Dmp53 in cells expressing
either wild-type Dmp53 alone (WT 1 C), Dmp53R155H alone (C 1 155), Dmp53H159N alone (C 1 159), wild-type Dmp53 plus Dmp53R155H
(WT 1 155), or wild-type Dmp53 plus Dmp53H159N (WT 1 159). Lane 1 contains 20 mg extract expressing an empty CMV vector.
For (A), (B), and (C), ªnonspecificº refers to a nonspecific protein/DNA complex present in the H1299 whole-cell extracts.
not shown). Given that p35 has previously been shown final wave of cell division posterior to the morphogenetic
furrow (Tomlinson and Ready, 1987; Wolff and Ready,to inhibit human p53-induced apoptosis in lepidopteran
(Prikhod'ko et al., 1999) and Drosophila cells (Yama- 1991). This unique aspect of development provides a
means to assay for similar effects of Dmp53 on the cellguchi et al., 1999), the lack of p35 suppression of apo-
ptosis may reflect different rates and/or levels of Dmp53 cycle. Transition of these cells from G1 to S phase in
wild-type discs can be detected by bromodeoxyuridineand p35 protein accumulation.
In addition to its ability to affect cell death pathways, (BrdU) incorporation into DNA (Wolff and Ready, 1991)
(Figures 4E and 4F). This transition from G1 to S phasemammalian p53 can induce cell cycle arrest at the G1
and G2/M checkpoints (Levine, 1997). In the Drosophila is not blocked or delayed by Dmp53 overexpression
from the gl-Dmp53 transgene (Figure 4F). In contrast,eye disc, the second mitotic wave is a synchronous,
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expression of human p21 or a Drosophila p21 homolog,
dacapo, under control of the same glass-responsive en-
hancer element completely blocks DNA replication in
the second mitotic wave (de Nooij and Hariharan, 1995;
de Nooij et al., 1996; and data not shown). However,
overexpression of Dmp53 does affect M phase in the
eye disc. In wild-type discs, an M phase±specific anti-
phospho-histone antibody typically stains a distinct
band of cells within the second mitotic wave (Figure
4G). In gl-Dmp53 larval eye discs, this band of cells is
present but is significantly broader and more diffuse
(Figure 4H), suggesting that Dmp53 alters the entry into
and/or duration of M phase.
Reduced Dmp53 Function Blocks
X Ray±Induced Apoptosis
We next sought to determine whether loss of Dmp53
function affected apoptosis or cell cycle arrest in re-
sponse to DNA damage. In order to examine the pheno-
type of tissues deficient in Dmp53 function, we expressed
the dominant-negative Dmp53 alleles described above as
transgenes under the control of tissue-specific promoters.
Coexpression of Dmp53R155H with wild-type Dmp53
suppresses the rough eye phenotype that normally re-
sults from wild-type Dmp53 overexpression (Figure 5C),
confirming that this mutant protein has dominant-nega-
tive activity in vivo. The same result was obtained by
expressing the Dmp53H159N protein (data not shown).
Unlike wild-type Dmp53, overexpression of the domi-
nant-negative alleles using the glass enhancer (Figure
5A) or a constitutive enhancer (arm-GAL4; data not
shown) has no visible effect on normal development.
In mammalian systems, p53-induced apoptosis plays
a crucial role in preventing the propagation of damaged
DNA (reviewed in Lowe, 1995). DNA damage also leads
to apoptosis in Drosophila. To determine if this response
requires the action of Dmp53, we expressed dominant-
negative Dmp53 transgenes in the posterior compart-
ment of the wing disc. Wild-type wing discs show wide-
spread apoptosis detectable by TUNEL staining 4 hr
after X irradiation (Figure 5E). When either dominant-
negative allele of Dmp53 is expressed in the posterior
compartment of the wing disc, apoptosis is blocked
Figure 4. Effects of Dmp53 Overexpression in Eye Discs in the cells expressing Dmp53, whereas the anterior
(A and B) Scanning electron micrographs of eyes from a wild-type compartment displays a normal amount of X ray±
fly (A) or a fly carrying one copy of the gl-Dmp53 transgene (B). induced cell death (Figures 5F and 5G). Thus, induction
(C and D) Dmp53 overexpression induces apoptosis. Eye discs were of apoptosis following X irradiation requires the function
dissected from a wild-type third instar larva (C) and a larva con-
of Dmp53. This proapoptotic role for Dmp53 appears totaining two copies of the gl-Dmp53 transgene (D). Discs are stained
be limited to a specific response to cellular damage,by TUNEL (green) to mark apoptotic cells and with anti-Dmp53
because developmentally programmed cell death in theantibody to show expression of Dmp53 (red).
(E and F) Dmp53 overexpression does not cause a G1 arrest in the eye and other tissues (Abrams et al., 1993) is unaffected
eye disc. A wild-type disc (E) and a disc containing one copy of the by expression of either dominant-negative Dmp53 allele
gl-Dmp53 transgene (F) were incubated with BrdU to label cells in (data not shown).
S phase (brown). Arrows indicate S phase cells of the second mitotic
Although our data strongly suggest that Dmp53 func-wave.
tion is required for X ray±induced apoptosis, it does not(G and H) Dmp53 overexpression alters the pattern of mitoses in
appear to be necessary for the cell cycle arrest inducedcells of the second mitotic wave. A wild-type disc (G) and a disc
containing one copy of the gl-Dmp53 transgene (H) were stained by the same dose of irradiation. In the absence of irradia-
with an anti-phospho-histone antibody that specifically labels mi- tion, a random pattern of mitosis is observed in third
totic cells (brown). Arrows indicate the normal position of the second instar wing discs of Drosophila (Figure 5H). Upon irradia-
mitotic wave.
tion, a cell cycle block in wild-type discs leads to a(I and J) Dmp53-induced apoptosis is suppressed by coexpression
significant decrease in anti-phospho-histone stainingof human p21. Discs containing one copy of the gl-Dmp53 transgene
(Figure 5I; Brodsky et al., 2000a). This cell cycle block(I) or one copy each of the gl-Dmp53 and gl-p21 transgenes (J) were
stained by TUNEL (green) and anti-Dmp53 antibody staining (red). is unaffected by expression of dominant-negative Dmp53
Cell
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Figure 5. Dominant-Negative Dmp53 Blocks
X Ray±Induced Apoptosis but Not X Ray±
Induced Cell Cycle Arrest
(A±C) Dmp53R155H suppresses Dmp53 ac-
tivity in vivo. Scanning electron micrographs
of eyes from flies carrying one copy of the
gl-Dmp53R155H transgene (A), one copy of
the wild-type gl-Dmp53 transgene (B), and
one copy each of the gl-Dmp53 and gl-
Dmp53R155H transgenes (C).
(D±G) Dmp53H159N blocks X ray±induced
apoptosis. Wing discs were dissected from
third instar larvae containing an engrailed-
GAL4 transgene. Apoptotic cells are stained
by TUNEL (green). Panels show an unirradi-
ated disc (D), a disc dissected 4 hr after X
irradiation (E), and a disc dissected 4 hr after
X irradiation carrying a UAS-Dmp53H159N
transgene shown with (F) and without (G) anti-
Dmp53 antibody staining (red). The UAS-
Dmp53H159N transgene is expressed specif-
ically in the posterior compartment of the
wing disc under the control of the engrailed-
GAL4 driver.
(H±K) Dmp53H159N does not block X ray±
induced cell cycle arrest. Wing discs were
dissected from third instar larvae containing
an engrailed-GAL4 transgene. Mitotic cells
are stained with anti-phopho-histone anti-
body (green). Panels show an unirradiated
disc (H), a disc dissected 4 hr after X irradia-
tion (I), and a disc dissected 4 hr after X irradi-
ation carrying a UAS-Dmp53H159N transgene
shown with (J) and without (K) anti-Dmp53
antibody staining (red).
in the posterior of the wing disc (Figures 5J and 5K). Dmp53 RNA is maternally loaded into oocytes and is
abundant until cellularization of the blastoderm. ZygoticSeveral time points after X irradiation were examined,
and all gave similar results, suggesting that both the expression of Dmp53 begins at cellularization and is
initially ubiquitous. At midembryogenesis, Dmp53 RNAonset and maintenance of the X ray±induced cell cycle
arrest is independent of Dmp53. levels are highest in the mesoderm and gut, with only
low levels of RNA detectable in the epidermal and neural
cell layers. As development proceeds, the expressionExpression of Dmp53 during Development
of Dmp53 becomes progressively more restricted andWe characterized the expression of Dmp53 transcripts
during embryogenesis to assess potential roles for falls dramatically in all tissues except for the primordial
germ cells and a small patch of hindgut cells. AlthoughDmp53 during Drosophila development (Figure 6).
Figure 6. Dmp53 RNA Expression during De-
velopment
(A) Stage 10 egg chamber showing high levels
of Dmp53 transcripts in the nurse cells (ar-
rowhead) and oocyte (arrow).
(B) Stage 3 embryo, showing high levels of
maternally loaded Dmp53 RNA filling the em-
bryo. Note that the posterior pole cells (pri-
mordial germ cells) are not stained (arrow-
heads in [B] and [C]). These cells are
transcriptionally quiescent until midembryo-
genesis (Su et al., 1998).
(C) Dmp53 maternal RNA levels are reduced
by stage 5 (cellular blastoderm).
(D) At stage 10, zygotic expression of Dmp53
RNA is highest in the mesoderm (arrow) and
developing gut (arrowhead).
(E) By stage 16, Dmp53 expression is dramat-
ically reduced in all tissues with the exception
of the primordial germ cells within the two
gonads (arrows) and a small portion of the
hindgut (not shown).
(F) Close up of Dmp53 expression within the
gonad of a stage 16 embryo.
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one must use caution when inferring function from ex- phase delay we observed is simply an indirect conse-
quence of the proapoptotic activity of Dmp53. The domi-pression data, the high levels of Dmp53 RNA in germ
nant-negative Dmp53 proteins had no detectable effectcells is likely to be significant because germline p53
on cell cycle arrest in response to X irradiation. However,expression is a common feature in species ranging from
this negative result does not rule out a function forclam (Van Beneden et al., 1997) to human (Bukovsky
Dmp53 in G2 arrest because the ATM/Chk1 pathway iset al., 1995; Quenby et al., 1999). This conservation of
conserved in Drosophila (Hari et al., 1995; Fogarty etexpression suggests an important function for p53 in
al., 1997) and may be sufficient to induce G2 arrestgermline development.
in response to radiation. We also cannot rule out the
possibility that our dominant-negative mutants might
somehow block the apoptotic function of Dmp53 with-Discussion
out eliminating a G2 checkpoint function. Thus, it re-
mains an open question whether Dmp53 might play aWe have identified and characterized a Drosophila ho-
role in radiation-induced G2 arrest.molog of p53. Our data show that, like mammalian p53,
As the most evolutionarily distant member of the p53Dmp53 is a sequence-specific DNA-binding protein
gene family to be identified, Dmp53 may shed light onwhose function is required to induce apoptosis in cells
the selective pressures that have maintained p53-likedamaged by X irradiation. Similar results are reported
molecules throughout evolution. The absence of p53in the accompanying paper by Brodsky et al. (2000b [this
function in mice increases the prevalence of defectiveissue of Cell]). Thus, the well-established proapoptotic
embryos and fetuses, particularly after exposure toactivity of vertebrate p53 is an ancient, conserved func-
drugs or radiation (Nicol et al., 1995; Norimura et al.,tion for this protein. However, there are also many intri-
1996). This embryo-protective role for p53 may haveguing differences between the mammalian and fly ver-
been a selective force for p53 evolution, since it wouldsions of p53. Perhaps the most noteworthy difference is
have a direct impact on reproductive success (Hall andthe likelihood that the ability to serve as a G1 checkpoint
Lane, 1997). Similarly, the expression of p53 in the germregulator is a more recent evolutionary development. It
cells of flies, clams, and mammals strongly suggestsis also probable that the relationship between p53 and
selection for germline p53 function during evolution. TheMDM2 is a later event in the course of evolution.
absence of p53 in mouse testes results in reduced spon-Overexpression of Dmp53 in larval eye discs has no
taneous germ cell apoptosis and an increased frequencyeffect on transition of cells from G1 to S phase. While
of abnormal sperm (Beumer et al., 1998; Yin et al., 1998).we do not know whether high levels of Dmp53 would
Thus, p53 may also have an important and conservedbe capable of affecting G1 in other cell types, this result
role in maintaining the fidelity of the germline throughmay reflect differences in the downstream targets of
the elimination of defective cells.vertebrate and Drosophila p53. In vertebrates, p53-
X irradiation of imaginal wing discs induces apoptosismediated G1 arrest is due primarily to transcriptional
that requires functional Dmp53. This poses the questionactivation of the cyclin-dependent kinase (cdk) inhibitor
of how Dmp53 activity is regulated in response to radia-p21, which can inhibit the CDKs that phosphorylate and
tion. It is well established that mammalian p53 receivesinactivate the retinoblastoma gene product (Rb). Phos-
signals from a variety of cellular stresses such as variousphorylated Rb family members release and activate E2F/
forms of DNA damage, nucleotide deprivation, incom-DP transcription factor complexes that are required for
plete DNA synthesis, and hypoxia. These signals arecell cycle progression (reviewed in Nevins et al., 1997).
likely to work through a set of signaling pathways thatThe cdk-Rb-E2F/DP pathway is highly conserved, and
activate and stabilize the p53 protein (reviewed in Giac-homologs of these genes regulate the cell cycle in Dro-
cia and Kastan, 1998; Prives and Hall, 1999). Althoughsophila (de Nooij et al., 1996; Du et al., 1996; Edgar and
understanding of the different gene products responsi-
Lehner, 1996; Lane et al., 1996). Overexpression of p21
ble for these various signaling pathways is still in its
or its Drosophila homolog, dacapo, in eye discs clearly
infancy, there is strong evidence that one pathway to
blocks the cell cycle in G1 (de Nooij and Hariharan, 1995; p53, that induced by irradiation, requires functional ATM
de Nooij et al., 1996). Therefore, the lack of a G1 arrest (reviewed in Morgan and Kastan, 1997). The ATM protein
in gl-Dmp53 discs suggests that expression of dacapo kinase shares homology with other members of the PI3
is not induced by Dmp53. This hypothesis is consistent kinase family, including the S. pombe DNA damage me-
with reports indicating that dacapo is not induced by X diator kinase Rad3 (Elledge, 1996). Recently, two ki-
irradiation (de Nooij et al., 1996). We speculate that, nases that are downstream of ATM, CHK1, and CDS1/
although all the necessary components of the p53 and CHK2 have been shown to phosphorylate and regulate
Rb pathways appear to be present in Drosophila, later human p53 (Chehab et al., 2000; Shieh et al., 2000).
events in evolution made p21 a target of p53 and thus Given that many aspects of the DNA damage checkpoint
established a dual role for p53 in apoptosis and G1 response are conserved between yeast and mammals,
checkpoint control. it is possible that Dmp53 might be similarly regulated.
Although overexpression of Dmp53 in the eye disc Indeed, Drosophila homologs of ATM (mei41) (Hari et
had no detectable effect on entry into S phase, it did al., 1995) and Chk1 (grapes) (Fogarty et al., 1997) have
appear to delay entry into M phase. Given that overex- been identified, and it will be interesting to determine
pression of human p53 can similarly delay entry into M their relationship to Dmp53. It should be mentioned here
phase (Agarwal et al., 1995; Stewart et al., 1995), it is that while ATM has been clearly shown to regulate p53-
possible that this G2 checkpoint function is conserved mediated cell cycle arrest, there is evidence that apo-
ptosis induced by p53 is independent of the function ofin Drosophila. However, it is also possible that the G2/M
Cell
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CO2 at 378C. Cells were transfected by a lipopolyamine-basedATM (Barlow et al., 1997; Liao et al., 1999). Thus, the
(Transfectam) protocol as described previously (Di Como et al.,study of Dmp53-induced apoptosis in Drosophila may
1999). Briefly, cells were grown in RPMI1640/10% FBS and trans-uncover new upstream regulators of p53 activity.
fected with various amounts of DNA. The precipitate was left on
The ability of mammalian p53 to induce apoptosis has the cells for 12 hr, after which fresh media was added for the
been studied in considerable detail. As mentioned in periods indicated. CMV-Dmp53, CMV-Dmp53R155H, and CMV-
Dmp53H159N express full-length Dmp53, Dmp53R155H, andthe introduction, a number of genes (e.g., Bax, IGF-
Dmp53H159N cDNAs from the cytomegalovirus (CMV) promoter inBP3, PIG3, etc.) have been identified that are induced
pRc/CMV (Invitrogen).in response to p53 and can cause apoptosis. Genes
H1299 cells were transfected in six-well, 9.6 cm2 plates with 2 mgsuch as hid, grim, and reaper, known to be involved
of DNA and harvested at 48 hr after transfection. Cells were lysed
in apoptosis in Drosophila (McCall and Steller, 1997; in 200 ml of lysis buffer (10 mM Tris-HCl [pH 7.5], 1 mM EDTA, 0.5%
Abrams, 1999), are being tested for their relationship to NP40, 150 mM NaCl, 1 mM DTT, 10% glycerol, 0.5 mM PMSF, and
a mixture of protease inhibitors), and the extracts were centrifugedDmp53. Brodsky et al. (2000b) report that reaper is,
at 16,000 3 g for 20 min to remove cell debris. Protein concentrationsin fact, a downstream target of Dmp53 transcriptional
were determined using the Bio-Rad assay using bovine globulin asactivation. There are reports as well that transcriptional
a standard (Bio-Rad Laboratories, CA). When necessary, total cellrepression may be a necessary component of some
extracts were frozen in a dry ice/alcohol bath and stored at 2808C.
aspects of the p53 apoptotic program (Shen and Shenk, For Western blot analysis, samples were electrophoresed through
1994; Sabbatini et al., 1995). DNA site selection (SELEX) an SDS-10% polyacrylamide gel. Protein gels were transferred to
polyvinylidene fluoride (PVDF) membranes (Millipore). For Dmp53or DNA arrays will be useful in identifying additional
detection, an anti-Dmp53 polyclonal antibody was used at a 1/3000Drosophila genes that are targets of Dmp53.
dilution. Proteins were visualized with an enhanced chemilumines-Our discovery of Dmp53 and its conserved role in
cence detection system (Amersham).radiation-induced apoptosis provides a new model sys-
Probes were made as follows: synthesized oligonucleotides (Op-
tem to study the function of a key tumor suppressor eron Technologies, Inc.) were self-annealed and end-labeled with
gene. Many important cellular pathways and functions T4 polynucleotide kinase (PNK) in the presence of [g-32P]ATP. The
oligonucleotide probe containing the p21 cis-acting p53-responsivehave been elucidated through the elegant genetics that
element (el-Deiry et al., 1993) is as follows: 59-TAGAGCGAACATGTDrosophila affords. The study of Dmp53 is likely to pro-
CCCAACATGTTGGCGTCG-39. The oligonucleotide probe con-vide new insights into pathways that regulate mamma-
taining the wild-type GADD45 cis-acting p53-responsive elementlian p53-induced apoptosis and may suggest new thera-
(Kastan et al., 1992) is as follows: 59-TAGAGCGAACATGTCTAAG
peutic approaches to cancer. CATGCTGGCGTCG-39. The oligonucleotide probe containing the
mutant GADD45 cis-acting element is as follows: 59-TAGAGC
Experimental Procedures GAAaATtTCTAAGaATtCTGGCGTCG-39. The p53 binding site is itali-
cized, and the mutated nucleotides are in lowercase lettering. The
Cloning of Dmp53 oligonucleotides were purified over a denaturing 16% acrylamide
A partial Dmp53 cDNA was found by a BLAST version 2.0 (Altschul gel, and both complementary strands were annealed and purified
et al., 1990) search of an EST database representing embryo, disc, over a native 10% acrylamide gel.
and adult head mRNA (C. K. et al., unpublished data). The full se- Electrophoretic mobility shift assays were performed as described
quence of Dmp53 was determined from three sources: sequencing a (Di Como and Prives, 1998), except for minor changes. Binding
commercially available cDNA clone (Research Genetics, ID #31553); reaction mixtures contained 20 mg mammalian whole-cell extract in
sequencing RACE products from embryo and adult Marathon-ready gel shift buffer (20 mM HEPES [pH 7.9], 25 mM KCl, 0.1 mM EDTA,
Drosophila cDNA libraries (Clontech); and sequencing genomic DNA 2 mM MgCl2, 0.5 mM DTT, 0.025% Nonidet P-40, 2 mM spermidine
from P1 clones DS01201, DS02942, DS05102, and DS06254 (Berke- [Sigma], 10% glycerol, 0.1 mg/ml acetylated bovine serum albumin
ley Drosophila Genome Project). Dominant-negative versions of [NEB]) and 120 ng double-stranded poly(d[I-C]) (Boehringher Mann-
Dmp53 containing the mutations R155H and H159N were generated heim) in a final volume of 30 ml. In all cases, volumes were equalized
by PCR-mediated mutagenesis. The p53-related genes from with lysis buffer. Reactions were incubated for 10 min at 248C, after
Tribolium castaneum and Leptinotarsa decemilineata were identi- which 5 ng of 32P-labeled oligonucleotide was added, and the incu-
fied by BLAST searches of internally generated EST databases. bation was continued at 248C for 15 min. Samples were run on
4.5% native polyacrylamide gels at 180±200V (not exceeding 40 mA
Sequence Analysis and Molecular Modeling current) in 0.53 TBE buffer at 248C for 1.5 hr. Gels were dried under
The multiple sequence alignment and phylogenetic tree were cre- vacuum at 808C and exposed to Kodak XAR film at 248C for
ated using the program ClustalW 1.7 (Thompson et al., 1994; freely 30±60 min.
available at ftp://ftp-igbmc.u-strasbg.fr/pub/ClustalW). The Gen-
bank identifier numbers for the sequences used in the alignment Drosophila Genetics
and/or tree are as follows: Loligo forbesi p53/73, gij1244762; Barbus Fly culture and crosses were performed according to standard pro-
cedures at 228C±258C. Dmp53, Dmp53R155H, and Dmp53H159Nbarbus p73, gij4689086; Mus musculus p73, gij4887145, p63,
gij3695094, and p53, gij53571; Homo sapiens p73, gij35214, transgenes were made by cloning a BclI/HincII fragment spanning
the Dmp53 open reading frame into pExpress-glass and pExpress-p63(KET), gij3970717, and p53, gij35214; Xenopus laevis p53,
gij545102; Danio rerio p53, 1778019. UAS transformation vectors. The pExpress vector is an adapted
version of the pGMR vector (Hay et al., 1994), which contains anSecondary structure predictions were made using the software
Simpa (Levin, 1997; http://www.embl-heidelberg.de/argos/simpa/). a-tubulin 39 UTR for increased mRNA stabilization and a modified
multiple cloning site. The pExpress-UAS vector is similar to pEx-A low-resolution three-dimensional model for Dmp53 residues 90±
275 was built using comparative structural modeling with the pro- press-glass except that it contains multiple UAS-GAL4 binding sites
in place of the glass binding sites. Standard P element±mediatedgram Modeler/InsightII 98.0 (Molecular Simulations, Inc.) (Sali and
Blundell, 1993; Sanchez and Sali, 1997). The coordinates for resi- germline transformation was used to generate transgenic lines con-
taining these constructs. For X irradiation experiments, third instardues 108±298 in the crystal structure of the human p53 DNA-binding
domain (PDB code 1TUP) (Cho et al., 1994) were used as the tem- larvae in vials were exposed to 4000 Rads of X rays using a Faxitron
X-ray cabinet system.plate. Figure 1B shows the alignment used in the calculations.
Electrophoretic Mobility Shift Assays Staining of Embryos and Discs
For immunocytochemistry, third instar larval eye and wing discsH1299 cells (American Type Culture Collection) were maintained in
RPMI1640 supplemented with 10% fetal bovine serum (FBS) in 5% were dissected in PBS, fixed in formaldehyde at room temperature
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(4% for 5 min for anti-phospho-histone or 2% for 30 min for anti- Barlow, C., Brown, K.D., Deng, C.X., Tagle, D.A., and Wynshaw-
Boris, A. (1997). Atm selectively regulates distinct p53-dependentDmp53 plus TUNEL), permeabilized in PBS 1 0.5% Triton (15 min at
room temperature), blocked in PBS 1 5% goat serum, and incubated cell-cycle checkpoint and apoptotic pathways Nat. Genet. 17, 453±
456. Erratum: Nat. Genet. 18(3), 1998.with primary antibody (2 hr at room temperature or overnight at 48C).
Anti-Dmp53 monoclonal antibody staining was performed using a Beumer, T.L., Roepers-Gajadien, H.L., Gademan, I.S., van Buul, P.P.,
1:2 dilution of hybridoma supernatant. Hybridoma clone H2 was Gil-Gomez, G., Rutgers, D.H., and de Rooij, D.G. (1998). The role of
used for anti-Dmp53 staining, and a mixture of supernatant from the tumor suppressor p53 in spermatogenesis. Cell Death Differ. 5,
clones H2, H4, and H5 were used to detect Dmp53R155H and 669±677.
Dmp53H159N. Anti-phospho-histone staining was performed using Bissonnette, N., and Hunting, D.J. (1998). p21-induced cycle arrest
an Anti-phospho-histone H3 Mitosis Marker (Upstate Biotechnol- in G1 protects cells from apoptosis induced by UV-irradiation or
ogy) at a 1:500 dilution. Goat anti-mouse or anti-rabbit secondary RNA polymerase II blockage. Oncogene 16, 3461±3469.
antibodies conjugated to FITC or Texas Red (Jackson Immunore-
Brachmann, R.K., Vidal, M., and Boeke, J.D. (1996). Dominant-nega-search) were used at a 1:200 dilution. Antibodies were diluted in
tive p53 mutations selected in yeast hit cancer hot spots. Proc. Natl.PBS 1 5% goat serum. TUNEL was performed using the Apoptag
Acad. Sci. USA 93, 4091±4095.Direct kit (Oncor) per manufacturer's protocol with a 0.5% Triton/
Brodsky, M.H., Sekelsky, J.J., Tsang, G., Hawley, R.S., and Rubin,PBS permeabilization step. Discs were mounted in anti-fade reagent
G.M. (2000a). mus304 encodes a novel DNA damage checkpoint(Molecular Probes), and images were obtained on a Leica confocal
protein required during Drosophila development. Genes Dev., inmicroscope. BrdU staining was performed as described (de Nooij
press.and Hariharan, 1995). In situ hybridization was performed as de-
scribed (Van Vactor and Kopczynski, 1999) using digoxygenin-labeled Brodsky, M.H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G.M.,
antisense RNA probes. and Abrams, J.M. (2000b). Drosophila p53 binds a damage response
element at the reaper locus. Cell 101, this issue, 103±113.
Generation of Anti-Dmp53 Antibodies Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha,
Anti-Dmp53 rabbit polyclonal and mouse monoclonal antibodies B., Seizinger, B.R., and Kley, N. (1995). Induction of the growth
were generated by standard methods using as antigen a full-length inhibitor IGF-binding protein 3 by p53. Nature 377, 646±649.
Dmp53 protein fused to glutathione-S-transferase (GST-Dmp53).
Bukovsky, A., Caudle, M.R., Keenan, J.A., Wimalasena, J., Foster,
Inclusion bodies of GST-Dmp53 were purified by centrifugation fol-
J.S., Upadhyaya, N.B., and van Meter, S.E. (1995). Expression of
lowing extraction in B-PER buffer (Pierce) and injected subcutane-
cell cycle regulatory proteins (p53, pRb) in the human female genital
ously into rabbits (Josman Labs) and mice (Antibody Solutions, Inc.)
tract. J. Assist. Reprod. Genet. 12, 123±131.
for immunization. The final boost for mouse monoclonal antibody
Chehab, N.H., Malikzay, A., Appel, M., and Halazonetis, T.D. (2000).production used intravenous injection of soluble GST-Dmp53 pro-
Chk2/hCds1 functions as a DNA damage checkpoint in G(1) byduced by solubilization of GST-Dmp53 in 6 M Guanidine-Hydro-
stabilizing p53. Genes Dev. 14, 278±288.chloride and dialysis into phosphate buffer containing 1 M NaCl.
Cho, Y., Gorina, S., Jeffrey, P.D., and Pavletich, N.P. (1994). CrystalHybridoma supernatants were screened by ELISA using soluble 63
structure of a p53 tumor suppressor-DNA complex: understandingHIS-tagged Dmp53 protein bound to Ni-NTA-coated plates (Qiagen)
tumorigenic mutations. Science 265, 346±355.and an anti-mouse IgG Fc fragment±specific secondary antibody.
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